Shanghai Fosun Pharmaceutical (Group) Co's market cap is currently $8.57B. The company's EPS TTM is $0.11; its P/E ratio is 18.13; and it has a dividend yield of 2.05%. Shanghai Fosun Pharmaceutical (Group) Co is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 41.40B	¥ 43.95B	¥ 39.01B	¥ 30.31B	¥ 28.59B
Gross Profit	¥ 19.68B	¥ 20.78B	¥ 18.78B	¥ 16.88B	¥ 17.04B
Operating Income	¥ 3.31B	¥ 8.30B	¥ 6.31B	¥ 4.72B	¥ 6.41B
EBITDA	¥ 7.55B	¥ 7.87B	¥ 8.70B	¥ 6.89B	¥ 7.07B
Net Income	¥ 2.39B	¥ 3.73B	¥ 4.73B	¥ 3.66B	¥ 3.32B
Balance Sheet
Cash & Short-Term Investments	¥ 15.58B	¥ 17.17B	¥ 14.55B	¥ 11.93B	¥ 9.99B
Total Assets	¥ 113.47B	¥ 107.16B	¥ 93.29B	¥ 83.69B	¥ 76.12B
Total Debt	¥ 30.28B	¥ 30.25B	¥ 24.25B	¥ 24.01B	¥ 21.91B
Net Debt	¥ 16.59B	¥ 14.01B	¥ 13.94B	¥ 14.05B	¥ 12.37B
Total Liabilities	¥ 56.85B	¥ 53.05B	¥ 44.92B	¥ 37.70B	¥ 36.92B
Stockholders' Equity	¥ 45.68B	¥ 44.58B	¥ 39.19B	¥ 37.00B	¥ 31.89B
Cash Flow
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	¥ 3.41B	¥ 4.22B	¥ 3.95B	¥ 2.58B	¥ 3.22B
Investing Cash Flow	¥ -3.82B	-	-	-	-
Financing Cash Flow	-	¥ 4.43B	-	¥ 1.47B	-

Currency in CNY

Shanghai Fosun Pharmaceutical (Group) Co Earnings and Revenue History

Income Statement >

Shanghai Fosun Pharmaceutical (Group) Co Debt to Assets

Balance Sheet >

Shanghai Fosun Pharmaceutical (Group) Co Cash Flow

Cash Flow >

Shanghai Fosun Pharmaceutical (Group) Co Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing